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ABSTRACT
Aim: This study assessed whether increased amino acid and energy intake in preterm
infants during the first week of life was associated with improved neurodevelopment at the
corrected age (CA) of 24 months.
Methods: We evaluated preterm infants from two consecutive cohorts in 2004 (Cohort 1)
and 2005 (Cohort 2) with different nutritional intakes in the Netherlands. Nutritional intake
and growth were recorded until week 5 and after discharge. Neurodevelopment was
determined using the Bayley Scales of Infant Development – Second Edition at a CA of
24 months.
Results: Compared to Cohort 1 (n = 56), Cohort 2 (n = 56) received higher nutritional
intake during week 1 (p < 0.001). The weight gain in Cohort 2 was higher until week 5,
especially among boys (p < 0.002). The mean Mental Developmental Index (MDI) scores
did not differ, but Cohort 2 was associated with an increased chance of having an
MDI ≥ 85, with an odds ratio of 6.4 and 95% confidence interval (CI) of 1.5–27.4, among
all girls with a higher protein intake (5.3, 1.2–23.3). The Psychomotor Developmental
Index increased with increasing nutritional intake, especially among boys (b-coefficient 3.1,
95% CI 0.2–6.0).
Conclusion: Higher nutritional intake was associated with different improvements in
growth and neurodevelopment in boys and girls.
INTRODUCTION
In addition to promoting growth similar to intra-uterine
foetal growth, adequate functional development is the main
goal of nutritional supplementation for preterm infants (1).
Postnatal growth has been associated with neurodevelop-
mental outcomes in very low birthweight (VLBW) infants
(2,3). In addition to postnatal weight gain, head growth may
serve as a predictor of brain growth and therefore of
neurodevelopmental outcomes (4). Follow-up studies of
children born preterm have indicated that subnormal head
growth predicted poorer intelligence quotient scores at
three and eight years of age (5,6). Poindexter et al. (7)
associated low early amino acid intake with increased risks
Abbreviations
BSDI-II, Bayley Scales of Infant Development – Second Edition;
CA, Corrected age; CLD, Chronic lung disease; GA, Gestational
age; HC, Head circumference; IRDS, Infant respiratory distress
syndrome; MDI, Mental Developmental Index; PDA, Patent
ductus arteriosus; PDI, Psychomotor Developmental Index; PN,
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Key notes
 This study assessed whether increased amino acid and
energy intake in preterm infants during the first week of
life was associated with improved neurodevelopment
at the corrected age of 24 months.
 We evaluated preterm infants from two consecutive
cohorts with different nutritional intakes in the Nether-
lands – 56 in 2004 and 56 in 2005.
 Higher nutritional intake was associated with different
improvements in growth and neurodevelopment in
boys and girls.
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of having a small-for-age head circumference (HC) at
18 months of age, specifically in boys.
In a retrospective study, Stephens et al. (8) determined
that higher nutritional intake in the first week of life was
associated with higher Mental Developmental Index (MDI)
scores and related this increase to higher protein and energy
intakes. Van den Akker et al. (9) suggested that the effects
of nutritional interventions in the first few days following
birth may be gender specific. VLBW boys, but not girls,
were affected by low amino acid and energy intakes when
assessed at a corrected age (CA) of 24 months. Previously,
we demonstrated that increased amino acid and energy
intakes during the first week of life were associated with a
statistically significant short-term improvement in weight
gain in VLBW infants (10). A secondary analysis of these
data revealed that this was mainly based on improvement in
male infants.
In this study, we investigated the neurodevelopment of the
surviving infants of the original cohorts in relation to early
nutritional intake. We hypothesised that nutritional supple-
mentation during the first week would not only improve
weight gain in the early postnatal period, but would also lead
to improved head growth and neurodevelopmental out-
comes at a CA of 24 months, specifically in boys.
METHODS
This study evaluated the long-term outcome data of a
previously described prospective cohort study that was
conducted during two consecutive years, 2004 (Cohort 1)
and 2005 (Cohort 2), to evaluate a change in the compo-
sition of standard parenteral nutrition (PN) (10). The study
was approved by the local ethics committee. The cohort
characteristics, the nutritional protocol and its modification
and the short-term results were described in detail in the
previous paper (10). The original study included preterm
infants born before 34 weeks of gestation who were
admitted to our tertiary neonatal intensive care unit at the
Radboud university medical center in the Netherlands on
the first day of life on the assumption that PN would be
needed for at least five days. Infants with major congenital
malformations or asphyxia were excluded from the study.
During both time periods, no major changes in clinical
practice occurred and all infants received nutrition accord-
ing to standard institutional protocols. The two cohorts
primarily differed in PN intake which consisted of standard
components, with higher amounts of amino acids and
carbohydrates for Cohort 2. According to the new protocol,
Cohort 2 achieved full PN two days earlier than Cohort 1, at
postnatal day 4 versus 6, respectively (10).
The intake of all nutrients via both PN and enteral
feeding, as well as growth characteristics, was recorded
daily during the first two weeks, weekly until week 5 and at
term-CA. Based on the information in the patient charts,
the mean daily weight gain was calculated weekly for the
first five weeks, according to Patel’s formula (11).
This study included the surviving participants of the
original cohorts who received standard follow-up care
provided for VLBW infants born prior to 32 weeks of
gestation or with a birthweight of <1500 g. In accordance
with the national follow-up programme, anthropometric
data were recorded at the CAs of six months, 12 and
24 months. The head circumference standard deviation
score (HC SDS) was calculated using the Swedish growth
reference for preterm infants and the Dutch reference of the
nationwide growth study from term-CA onwards (12,13).
SDSs for weight and length were calculated using the Dutch
reference (12). In addition, a neurodevelopmental assess-
ment using the Bayley Scales of Infant Development –
Second Edition (BSID-II) was performed at 24 months of
CA, resulting in MDI and Psychomotor Developmental
Index (PDI). Scores of 85 or above were categorised as
normal outcomes, whereas scores between 70 and 85
reflected moderate impairment and scores below 70 indi-
cated severe impairment. (14) We assumed the diagnosis of
normal neurodevelopmental outcome as clinically relevant
and therefore dichotomised the MDI and PDI scores with a
cut-off score of ≥85 reflecting normal outcome and score of
below 85 reflecting neurodevelopmental impairment.
The original cohort study was powered to assess differ-
ences in postnatal growth. As this study only evaluated the
surviving infants of these cohorts, no power calculation was
carried out. The statistical analyses were performed using
IBM SPSS statistics, version 22.0 for Windows (IBM SPSS
Inc., Chicago, IL, USA). As the values of the continuous
variables were normally distributed, mean differences with
95% confidence intervals (95% CI) were calculated
between the two cohorts. For dichotomous data, odds
ratios (OR) with 95% CIs were calculated. Subsequently,
linear regression analyses were performed to assess the
effects on the continuous MDI and PDI scores of infants
belonging to Cohort 1 or 2. These analyses were also used
for protein and energy intake in week 1, separately and
simultaneously, adjusted for a potential confounder set that
included gender, gestational age (GA), birthweight, mater-
nal education, infant respiratory distress syndrome (IRDS),
days on ventilator, indomethacin treatment and late-onset
sepsis. This confounder set was reduced if the model was
unstable or when interpretation issues called for greater
precision, by manually excluding those variables that did
not change the effect estimate by more than 10% when they
were excluded. Logistic regression analyses were performed
for the dichotomous outcomes MDI ≥ 85 and PDI ≥ 85. All
analyses were performed for the total study population and
separately for the subgroups of boys and girls.
RESULTS
The original Cohort 1 comprised 68 infants (38 girls), while
Cohort 2 comprised 79 infants (37 girls). The detailed
cohort characteristics have previously been reported (10).
For this study, we evaluated all 112 surviving children who
visited the routine follow-up at the CA of 24 months. A
further six infants had died, two from Cohort 1 and four
from Cohort 2, while three and nine infants from the two
respective cohorts were not invited, according to the
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criteria of the follow-up programme, and 7 and 10 infants
did not participate in the 24-month follow-up (Fig. 1).
Cohort characteristics
The cohort characteristics for the participating children,
and the potential determinants of the outcomes, are
presented in Table 1. Mean GA and birthweight did not
differ between the two cohorts, but the duration of
mechanical ventilation was 1.4 days shorter for infants in
Cohort 2. Concerning nutritional intake, Cohort 2 received
3.3 (95% CI 2.0–4.6) g/kg/week more protein than Cohort
1 and had a 92 (54–131) kcal/kg/week higher energy intake
during the first week. These differences were slightly smaller
during the second week.
Only small differences were seen between the two
cohorts with regard to gender, the numbers of infants with
prematurity-related morbidities and maternal education.
The only exception was patent ductus arteriosus (PDA), and
its treatment, which occurred more frequently among
infants in Cohort 1. Independent of cohort status, male
infants seemed to have had an increased risk of IRDS and
chronic lung disease (CLD) compared to female infants
(OR 2.5, 95% CI 1.1–5.6 and 3.1, 1.0–9.6, respectively).
Growth and neurodevelopmental outcomes
The outcome parameters postnatal growth velocity, HC
SDSs and BSID-II scores are presented in Table 2. The
infants in Cohort 2 exhibited a higher mean daily weight
gain from birth through to week 5 compared to Cohort 1,
with a mean difference of 1.8 (95% CI 0.7–3.0) g/kg/day
that was mainly due to a 3.1 (1.3–4.8) g/kg/day higher
weight gain in male infants. The HC SDS in week one was
lower in Cohort 2 than Cohort 1, but at the CA of six
months, the HC SDS was normal compared to the Dutch
population for both cohorts. This means that infants
in Cohort 2 achieved a greater catch-up growth for
Figure 1 Consort diagram. PN = parenteral nutrition; VLBWI = very low birthweight infants (GA < 32 weeks or birthweight < 1500 g; BSID-II = Bayley Scales of
Infant Development – Second Edition; GA = gestational age.
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HC (0.6 SDS; 0.2–0.9) compared to Cohort 1. At the CA of
24 months, the weight, length and HC were not different
between the cohorts and within the normal range compared
to the reference population.
In Cohort 1, 10 infants could not be tested for MDI
adequately, because they were unable to complete the tests
or were easily distracted. As their parents reported concerns
regarding their behaviour, and they all had PDI scores of
<70, these infants were categorised into the group with an
MDI of <85. One infant refused to cooperate with MDI
testing and was excluded from the analysis. The mean MDI
and PDI scores were not different between the two cohorts,
either in the total group or in the subgroups of boys and
girls. However, the girls in both cohorts achieved higher
scores than the boys, especially in Cohort 1 with a mean
difference MDI of 12.7 (95% CI 5.2–20.2), PDI of 9.4 (0.8–
18.0). In Cohort 2, the differences between boys and girls
were smaller, with a mean difference for MDI of 6.3 (95%
CI 1.2–13.8) and 5.5 (4.1 to 14.9) for PDI.
The children in Cohort 1 also seemed to be at increased
risk of having an MDI below 85 (OR 2.1, 95% CI 0.9–5.4)
compared to Cohort 2. Subgroup analyses by MDI revealed
that children with an MDI below 85 had a lower mean
protein intake during the first week of life compared to
children with an MDI of ≥85: 14.9 versus 16.8 g/kg/week
with a mean difference of 1.8 (95% CI 0.1–3.5). Further-
more, an MDI below 85 seemed to be associated with
having had a PDA (OR 1.9, 95% CI 0.8–4.7), IRDS (2.2,
0.8–6.0) or CLD (3.3, 1.1–10.1) and with ≤10 years of
maternal education (4.0, 1.3–13.8). For children with a PDI
below 85, the same associations were seen but with slightly
lower effect estimates: PDI < 85 PDA (OR 1.6, 95% CI 0.8–
3.8), IRDS (2.2, 1.0–4.8), CLD (2.6, 0.8–8.8) and maternal
education (2.5, 0.8–7.6). Compared to girls, boys seemed to
have increased risks of having an MDI below 85 (OR 5.1,
95% CI 1.8–14.0) and a PDI below 85 (1.9, 0.9–4.0).
Effect of early nutrition on neurodevelopmental scores
and outcomes
Table 3 presents the results of the linear regression analysis
of the effects of early nutritional intake on the continuous
neurodevelopmental outcome scores adjusted for con-
founders. Table 4 presents the results of the logistic regres-
sion analysis of the chance to achieve a normal
neurodevelopmental outcome in relation to early nutri-
tional intake adjusted for confounders. The different nutri-
tional protocols in Cohorts 1 and Cohort 2 did not
influence the mean MDI scores, either in the total study
Table 1 Cohort characteristics and potential determinants of the outcomes
Cohort 1 (n = 56), mean (SD) Cohort 2 (n = 56), mean (SD) Mean difference (C2C1) 95% CI
Patient characteristics
Gestational age in weeks* 29.3 (2.2) 29.6 (1.8) 0.3 0.4 to 1.1
Birthweight in grams* 1124 (290) 1153 (330) 29 87 to 146
Head circumference of week 1 in cm 26.5 (2.2) 26.7 (1.8) 0.3 1.1 to 0.6
Days of mechanical ventilation* 3.8 (4.3) 2.4 (3.5) 1.4 2.9 to 0.1
Nutritional intake
Protein week 1 (g/kg/week) 14.7 (3.4) 18.0 (3.6) 3.3 2.0 to 4.6
Protein week 2 (g/kg/week) 21.1 (5.0) 22.8 (4.8) 1.8 0.1 to 3.6
Energy week 1 (kcal/kg/week) 513 (94) 605 (111) 92 54 to 131
Energy week 2 (kcal/kg/week) 710 (173) 777 (165) 68 5 to 131
Cohort 1 (n = 56), number (%) Cohort 2 (n = 56), number (%) OR (C1 versus C2) 95% CI
Potential determinants of the outcomes
Gender, female* 32 (57) 27 (48) 1.4 0.7 to 3.0
IUGR 9 (16) 11 (20) 0.8 0.3 to 2.1
IRDS* 38 (68) 33 (59) 1.5 0.7 to 3.2
CLD 10 (18) 6 (11) 1.8 0.6 to 5.4
PDA 28 (50) 17 (30) 2.3 1.1 to 5.0
PDA treatment* 25 (45) 12 (21) 3.0 1.3 to 6.8
LOS* 26 (46) 26 (46) 1.0 0.5 to 2.1
NEC > 1b 3 (5) 5 (9) 0.6 0.1 to 2.5
IVH grade 3/4 3 (5) 1 (2) 3.1 0.3 to 30.9
Maternal education* low/high
(missing)
10/37 (9) 8/37 (11) 1.3 0.4 to 3.5
C1 = Cohort 1; C2 = Cohort 2; OR = Odds ratio; 95% CI = 95% Confidence interval; IUGR = Intra-uterine growth retardation defined as a birthweight
< 10th percentile; IRDS = Infant respiratory distress syndrome; CLD = Chronic lung disease defined as supplemental oxygen for >28 days; PDA = Patent
ductus arteriosus diagnosed by echocardiography; PDA treatment = Including up to three courses of indomethacin and, or, surgical ligation; LOS = Late-onset
sepsis defined by positive blood culture and clinical signs of infection occurring more than 72 hours after birth; NEC = Necrotising enterocolitis defined
by Bell’s stage > 1b; IVH = Intraventricular haemorrhage; Low maternal education = ≤10 years of education.
*Included in potential confounder set in multivariable analyses (IUGR, CLD and PDA not included because of large overlap with other variables and NEC and
IVH not included because of small numbers).
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population or in the subgroups of boys and girls. However,
a 1 g/kg higher intake of protein adjusted for energy in
week one was associated with an increase in the PDI score
of 2.4 (95% CI 0.6–4.3), especially among the boys (3.1, 0.2–
6.0). This led to an approximately 1.5 higher chance of
having a PDI ≥ 85 per g/kg higher protein intake (OR 1.4,
95% CI 1.1–1.8), and this was also more pronounced among
the boys (Table 4). Cohort 2 was associated with a
markedly higher chance of having an MDI ≥ 85 in the
total study population (6.4; 1.5–27.4), as well as for boys
and girls separately. Among girls, a positive influence of
protein intake on the chance of having an MDI ≥ 85, with
or without an adjustment for energy intake, was also
observed (5.3, 1.2–23.3 and 2.8, 1.1–6.8, respectively).
DISCUSSION
Our evaluation of two cohorts at the CA of 24 months
indicated that infants who received more protein and
energy during the first week of life demonstrated a short-
term improvement in postnatal weight gain, especially
among male infants, while catch-up growth in HC seemed
to be improved as well. The mean BSID-II scores were not
different between the two cohorts, and the MDI scores did
not seem to be influenced by the nutritional protocol.
However, we found differences in the subgroups of chil-
dren, namely boys and girls. Children in Cohort 2 were
more likely to have an MDI ≥ 85, which was clearly
associated with a higher protein intake among girls, while
higher protein intake had a positive effect on the PDI score
among boys.
While HC growth has been related to neurodevelopmen-
tal outcome, two randomised trials demonstrated that
impaired head growth was associated with the persistence
of cumulative protein and energy deficits and that postnatal
abnormal head growth was ameliorated via the optimisa-
tion of nutritional intake, especially parenteral intake
(15,16). The improved catch-up in HC we saw with
improved nutrition was in accordance with the results of
the above-mentioned trials.
A systematic review evaluated the effects of increased
nutritional intake in the neonatal period on
Table 2 Postnatal growth and neurodevelopmental outcomes
Cohort 1 (n = 56) Cohort 2 (n = 56) Mean difference (C2C1) 95% CI
Growth velocity from birth through week 5 [g/kg/day; mean (SD)]
Total cohort 9.4 (3.0) 11.3 (2.9) 1.8 0.7 to 3.0
Girls 10.0 (2.7) 10.7 (2.9) 0.7 0.8 to 2.2
Boys 8.8 (3.4) 11.8 (2.9) 3.1 1.3 to 4.8
Head circumference [standard deviation score; mean (SD)]
Week 1 1.0 (1.1) 1.6 (1.0) 0.5 1.0 to 0.1
Month 6 0.1 (1.3) 0.05 (0.9) 0.2 0.3 to 0.6
Month 6–week 1* 1.1 (0.7) 1.7 (0.8) 0.6 0.2 to 0.9
Anthropometry at CA of 24 months [standard deviation score; mean (SD)]
Head circumference 0.2 (1.2) 0.2 (1.0) 0.0 0.4 to 0.4
Weight 0.7 (1.0) 0.6 (0.9) 0.1 0.8 to 0.4
Length 0.5 (1.0) 0.4 (0.9) 0.2 0.8 to 0.6
BSID-II [continuous scores; mean (SD)]
MDI total cohort 98 (13) 99 (14) 1.1 4.4 to 6.6
Girls 103 (10) 103 (12) 0.4 6.4 to 5.5
Boys 90 (14) 96 (16) 6.0 3.5 to 15.4
PDI total cohort 84 (16) 87 (17) 3.1 3.4 to 9.5
Girls 88 (16) 90 (17) 1.7 7.2 to 10.6
Boys 79 (16) 84 (17) 5.7 3.6 to 15.0
OR (C 1 versus C 2) 95% CI
BSID-II [dichotomous; number (%)]
MDI < 85 (n) 16 (29) 9 (16) 2.1 0.9 to 5.4
MDI ≥ 85 (n) 39 (71) 47 (84)
PDI < 85 (n) 33 (59) 30 (54) 1.2 0.6 to 2.6
PDI ≥ 85 (n) 23 (41) 26 (46)
C1 = Cohort 1; C2 = Cohort 2; OR = Odds ratio; 95% CI = 95% Confidence interval; Month 6–week 1* = Change in SDS from birth until six months of
corrected age (CA); BSID-II = Bayley Scores of Infant Development – Second Edition at 24 months CA (14); MDI = Mental Developmental Index
(n = 45/56); PDI = Psychomotor Developmental Index (n = 54/54); MDI and PDI < 85 = Moderately to severely impaired mental or psychomotor
development, including not being able to perform the BSID-II.
Growth velocity (n = 54/54) calculated using the exponential formula described by Patel et al. (11). Head circumference standard deviation score
(HC SDS) calculated using the Swedish growth reference for preterm infants and the Dutch reference of the nationwide growth study at six months CA
(week 1 n = 45/42; month 6 = 52/51; month 6–week 1 n = 46/40) (12,13). Weight and length SDSs were calculated using the Dutch reference (12).
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neurodevelopmental outcomes in VLBW infants, and the
results were comparable to our cohorts (17). This review
evaluated 15 studies with regard to differences in neurode-
velopmental scores and survival without impairment. The
relationship between increased nutrition and neurodevel-
opmental outcomes remained unclear, probably due to the
variety of nutritional interventions and neurodevelopmen-
tal outcome measures. In contrast, we not only compared
the differences between the cohorts, but also evaluated the
mental developmental and psychomotor indices in relation
to the individual nutritional intake of the first week,
adjusting for a number of confounders of neurodevelop-
ment and evaluated subgroups of children. In general,
preterm infants have been shown to be at risk for adverse
neurodevelopmental outcomes associated with socio-
economic status and gender, as well as with a number of
clinical factors that may be related to each other (18).
Therefore, it is difficult to evaluate the effect of a single
determinant, such as nutritional intake. In our study, for
instance, the diagnosis and treatment of PDA seemed to be
important risk factors for adverse outcome, but children
with a PDA also had a lower protein and energy intake
during the first 2 weeks compared to children without
PDA. However, by including treatment for PDA in our
confounder set, we were able to estimate the effects of
protein and energy intake independent of PDA and other
determinants of neurodevelopmental outcomes in preterm-
born children. The same holds true for the other relevant
confounders included in our analyses. However, some
residual confounding by maternal education may still have
been present in our results due to the relatively large
number of missing values for this variable.
There is no consensus on whether improvements in
postnatal weight gain and neurodevelopment are a result of
a higher intake of amino acids (2,3,19). A Cochrane review
found no evidence that high doses of amino acids had a
positive effect on neurological outcomes (20). In contrast,
van den Akker et al. (9) presented the long-term outcome
results of a randomised trial that evaluated the early
administration of amino acids and indicated that the
intervention group, especially the male infants who
received amino acids immediately after birth, experienced
fewer disabilities at the CA of 24 months. Vlaardingerbroek
et al. (21) demonstrated that high levels of amino acids
and nonprotein energy sources were needed to achieve an
anabolic state in VLBW infants. Our findings are in
accordance with the latter study because Cohort 2 received
not only more amino acids, but also an increase in
energy (9).
Gender seemed to be an important factor that deter-
mined the consequences of nutritional interventions, both
in our study on short-term growth effects, and in other
studies (9,10,22–24). While the general male disadvantage
regarding mortality, morbidity and neurodevelopmental
outcomes among VLBW infants is well established, the
above-mentioned nutritional intervention studies found
Table 3 Effects of early nutritional intake on neurodevelopmental outcome scores
MDI score* PDI score*
Crude b Adjusted b 95% CI Crude b Adjusted b 95% CI
Total population (n = 112)
Cohort 2 1.12 2.56 2.58 to 7.70 3.07 1.78 4.52 to 8.09
Protein week 1 and
Energy week 1
0.17 and
0.01
0.37 and
0.01
1.33 to 2.08 and
0.06 to 0.05
2.46 and
0.05
2.44† and
0.06
0.55 to 4.32 and
0.12 to 0.00
Protein week 1 0.12 0.18 0.68 to 1.04 1.16 0.80 0.22 to 1.83
Energy week 1 0.01 0.00 0.03 to 0.03 0.03 0.01 0.03 to 0.04
Boys (n = 53)
Cohort 2 5.98 6.79 2.71 to 16.28 5.69 2.47 7.68 to 12.61
Protein week 1 and
Energy week 1
0.21 and
0.03
0.52 and
0.01
2.41 to 3.44 and
0.10 to 0.11
2.98 and
0.05
3.08‡ and
0.04
0.19 to 5.98 and
0.15 to 0.06
Protein week 1 0.88 0.64 0.89 to 2.18 1.74 1.26 0.44 to 2.97
Energy week 1 0.03 0.02 0.34 to 0.08 0.05 0.02 0.04 to 0.08
Girls (n = 59)
Cohort 2 0.41 0.57 6.87 to 5.72 1.70 0.97 10.21 to 8.28
Protein week 1 and
Energy week 1
0.41 and
0.00
0.06 and
0.05
2.14 to 2.26 and
0.08 to 0.05
2.03 and
0.05
1.38 and
0.04
1.67 to 4.42 and
0.13 to 0.05
Protein week 1 0.44 0.38 1.43 to 0.68 0.72 0.09 1.38 to 1.56
Energy week 1 0.01 0.01 0.04 to 0.02 0.01 0.01 0.05 to 0.04
MDI = Mental Developmental Index; PDI = Psychomotor Developmental Index; 95% CI = 95% Confidence interval.
Bold numbers = indicative of an effect. Linear regression effect sizes were estimated for four separate situations: (i) being a member of Cohort 2, (ii) the
combination of protein and energy intake in week 1, (iii) protein intake in week 1 alone and (iv) energy intake in week 1 alone.
*All analyses were adjusted for the potential confounder set: gender, gestational age, birthweight, maternal education, infant respiratory distress syndrome,
days on ventilator, indomethacin treatment and late-onset sepsis, unless otherwise indicated.
†Adjusted for gender, maternal education and days on ventilator only.
‡Adjusted for maternal education only.
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that higher intake was specifically advantageous for male
infants (25,26). Male vulnerability in outcomes has been
related to higher perinatal testosterone and cortisol con-
centrations and an impaired adaptive response to stress that
may have an influence on brain development (27,28). Also,
studies have demonstrated gender-specific differences in
early brain maturation (29,30). All of this may indicate
different requirements of nutritional intake for male and
female infants in the early postnatal period, and this could
explain the different effects on neurodevelopmental out-
comes for boys and girls that we observed.
In accordance with the study of van den Akker et al. (9),
our results indicate that both male and female infants were
vulnerable to nutritional deficits, but may have had different
needs. Even short-term interventions may have significant
effects for male and female infants, either inducing harm if
the nutritional intake is inadequate or preventing poor
neurological outcomes if the nutritional needs are met.
In addition to the strengths mentioned above, this study
also had some limitations. First, the patients were not
randomly assigned to a treatment, but were recruited over
two time periods. However, all patients received nutrition
according to a standardised protocol, the data were
recorded in the same standardised manner, and the results
were corrected for disparities in patient characteristics and
morbidities. Second, although we improved the nutritional
intake in Cohort 2, these infants did still not receive the
intake recommended by guidelines issued after the two
study periods (1,10). This factor may have attenuated our
results, for both boys and girls. Furthermore, this study was
not designed and powered to evaluate gender differences.
Nevertheless, our data are consistent with recent studies
and thus indicate that it may be necessary to develop
different nutritional strategies for specific subgroups of
preterm infants.
CONCLUSION
This study showed that an increase in the intake of amino
acids and energy during the first week of life was associated
with improved short-term weight gain, possibly improved
catch-up of head growth and several specific long-term
neurodevelopmental outcomes among preterm-born boys
and girls at the CA of two years. Our findings indicate a
need for adequately powered and randomised studies to
evaluate gender-specific nutritional needs in preterm
infants.
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0.99
1.38† and
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Boys (n = 53)
Cohort 2 2.41 6.32‡ 1.03 to 38.88 1.71 0.73 0.17 to 3.2
Protein week 1 and
Energy week 1
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0.98 to 1.01
1.50 and
1.00
1.77§ and
0.98
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0.98 to 1.00
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MDI = Mental Developmental Index; PDI = Psychomotor Developmental Index; OR = Odds ratio; 95% CI = 95% Confidence interval.
Bold numbers = indicative of an effect. Scores ≥ 85 reflect normal neurodevelopment. Logistic regression odds ratios were analysed for four independent
variables (i) being a member of Cohort 2, (ii) the combination of protein and energy intake in week 1, (iii) protein intake in week 1 alone and (iv) energy
intake in week 1 alone.
*All analyses were adjusted for the potential confounder set: gender, gestational age (GA), birthweight, maternal education, infant respiratory distress
syndrome (IRDS), days on ventilator, indomethacin treatment and late-onset sepsis, unless otherwise indicated.
†Adjusted for maternal education only.
‡Adjusted for GA, birthweight, maternal education, indomethacin treatment and late-onset sepsis.
§Adjusted for maternal education, IRDS, days on ventilator, indomethacin treatment and late-onset sepsis.
¶Adjusted for maternal education and days on ventilator only.
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